The Insides News- The Insides Neo - fistuloclysis, distal feeding, best, alternative to parenteral nutrition, fistula, ostomy, ileostomy, chyme, enteral, oral nutrition, enteromate, intestinal failure, colon cancer, bowel cancer, gut cancer, ostomy appliance, high output, chyme, dehydration, defunctioned, ileus, lars, microbiome, lower interior resection syndrome, incontinent, incontinence, gut health, reversal surgery
University of Auckland Researchers Using The Insides System in Randomised Controlled Trial

University of Auckland Researchers Using The Insides® System in Randomised Controlled Trial

August 19, 2020

Press Release
Source: The Insides Company Limited
On: Wednesday 19 August 2020 – Auckland

Companies: The Insides Company Limited

The Insides Company’s premier chyme reinfusion device, The Insides System, has been selected by researchers at the University of Auckland for a pivotal clinical trial.

For patients with temporary ileostomies, fluid and nutrient loss is a serious side effect. The Insides Company has invented a novel device to recycle these contents to the patient and prevent many of the associated complications.

Researchers at the University of Auckland have been awarded a grant from the Health Research Council of New Zealand in the amount of $1.4 million. This grant will fund a randomised controlled trial of this medical device. This study is currently enrolling participants at Auckland City Hospital and is expected to run for 3 years.

Choose Your Language

Selecting language below will change the language for